These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 4580)

  • 21. The effect of pronounced hypoglycemia on monoamine metabolism in rat brain.
    Agardh CD; Carlsson A; Linqvist M; Siesjö BK
    Diabetes; 1979 Sep; 28(9):804-9. PubMed ID: 467805
    [No Abstract]   [Full Text] [Related]  

  • 22. Short-term and long-term effects of methamphetamine on biogenic amine metabolism in extra-striatal dopaminergic nuclei.
    Morgan ME; Gibb JW
    Neuropharmacology; 1980 Oct; 19(10):989-95. PubMed ID: 6106905
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term effects of 5,7-dihydroxytryptamine on brain monoamines.
    Jacoby JH; Lytle LD; Nelson MF
    Life Sci; 1974 Mar; 14(5):909-19. PubMed ID: 4828406
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain tyrosine hydroxylation: alteration of oxygen affinity in vivo by immobilization or electroshock in the rat.
    Davis JN
    J Neurochem; 1976 Jul; 27(1):211-5. PubMed ID: 8590
    [No Abstract]   [Full Text] [Related]  

  • 26. Serotonergic-dopaminergic interactions: implications for hyperkinetic disorders.
    Gabay S
    Adv Exp Med Biol; 1981; 133():585-601. PubMed ID: 6172019
    [No Abstract]   [Full Text] [Related]  

  • 27. Neurochemical changes following the administration of precursors of biogenic amines.
    Smith JE; Lane JD; Shea PA; McBride WJ
    Life Sci; 1977 Aug; 21(3):301-6. PubMed ID: 19668
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain.
    Robinson DS; Campbell IC; Walker M; Statham NJ; Lovenberg W; Murphy DL
    Neuropharmacology; 1979 Oct; 18(10):771-6. PubMed ID: 42024
    [No Abstract]   [Full Text] [Related]  

  • 29. Undernutrition and the development of brain neurotransmitter systems.
    Wiggins RC; Fuller G; Enna SJ
    Life Sci; 1984 Nov; 35(21):2085-94. PubMed ID: 6149444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of serotonin and catecholamine metabolism in cats trained to perform a delayed response task.
    Vachon L; Roberge AG
    Neuroscience; 1981; 6(2):189-94. PubMed ID: 6164007
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes in brain amines associated with cancer anorexia.
    Chance WT; von Meyenfeldt MF; Fischer JE
    Neurosci Biobehav Rev; 1983; 7(4):471-9. PubMed ID: 6199701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid hormone control of 5-hydroxytryptamine metabolism in developing rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1974 Oct; 191(1):72-81. PubMed ID: 4422815
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):242-53. PubMed ID: 4363855
    [No Abstract]   [Full Text] [Related]  

  • 34. Synaptosomal uptake of norepinephrine and 5-hydroxytryptamine and synthesis of catecholamines during benzodiazepine treatment.
    Rastogi RB; Lapierre YD; Singhal RL
    Can J Physiol Pharmacol; 1978 Oct; 56(5):777-84. PubMed ID: 30525
    [No Abstract]   [Full Text] [Related]  

  • 35. Nerve growth factor: effects on D-amphetamine-induced activity and brain monoamines.
    Lewis ME; Brown RM; Brownstein MJ; Hart T; Stein DG
    Brain Res; 1979 Nov; 176(2):297-310. PubMed ID: 40668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurochemical changes in brain during ongoing behavior.
    Loullis CC; Hellhammer DH
    Ann N Y Acad Sci; 1986; 473():349-66. PubMed ID: 2432824
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective increase of brain dopamine synthesis by sulpiride.
    Tagliamonte A; DeMontis G; Olianas M; Vargiu L; Corsini GU; Gessa GL
    J Neurochem; 1975 Apr; 24(4):707-10. PubMed ID: 1123624
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat.
    Jancsàr SM; Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):263-9. PubMed ID: 6204359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of taurine on the decreased biogenic amine neurotransmitter levels in the brain of mice exposed to arsenic.
    Liu X; Piao F; Li Y
    Adv Exp Med Biol; 2013; 776():277-87. PubMed ID: 23392890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).
    Winn SR; Scherer T; Thöny B; Harding CO
    Mol Genet Metab; 2016 Jan; 117(1):5-11. PubMed ID: 26653793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.